| Document |
Document Title |
|
WO/2023/232944A2 |
The present invention relates to a method of making a composition comprising a film-coated porous material and the corresponding composition. The invention further relates to the use of this product in cosmetic skin treatment and treatme...
|
|
WO/2023/234906A1 |
The present invention relates to a test device (1) for measuring liquid absorption (swelling) capacity of polymers on a mass basis automatically.
|
|
WO/2023/234886A1 |
The invention relates to cryogel / nanofiber hybrid biomaterial thereof for use as soft tissue implants in biomedical fields such as bone tissue engineering, nerve regeneration, dental and eye applications.
|
|
WO/2023/233015A1 |
A composition for use in an immobilization device for immobilizing at least a portion of a body part comprising, based on total weight of the composition, a. 30 to 62 wt% of a first polymer with a melting temperature below 100°C, prefer...
|
|
WO/2023/229557A1 |
The invention relates to a biocompatible and biodegradable polymer composite film having properties of adhesion and healing on wet surfaces comprising hydroxypropyl methylcellulose, film-forming agent, carrier, and lubricant. The polymer...
|
|
WO/2023/230285A1 |
Disclosed herein include methods of killing or preventing growth of one or more biological contaminants and/or pathogens on or in a subject.
|
|
WO/2023/222291A1 |
The invention relates to a wound dressing comprising a needled nonwoven that contains: - 30 wt.% to 80 wt.%, in relation to the total weight of the needled nonwoven, of superabsorbent fibers; and - 70 wt.% to 20 wt.%, in relation to the ...
|
|
WO/2023/225547A1 |
Hemp-based absorbent articles are disclosed. The absorbent article can be a tampon or pad for feminine hygiene. The absorbent article can be flushable or compostable. In one example, the absorbent article is a flushable tampon for femini...
|
|
WO/2023/223316A1 |
A layer for a reusable liquid-absorbent article of clothing, configured to constitute an upper layer of an absorbent pad intended for contact with a body of a user, is formed of a knitted fabric. The layer comprises a pattern of areas kn...
|
|
WO/2023/224427A1 |
The present application relates a polymer material and a use thereof. The present application can provide a polymer material that has both excellent biodegradability and excellent absorbency by using a polysaccharide component capable of...
|
|
WO/2023/224872A1 |
Provided herein is a dressing for use with a catheter assembly, including a base defining a perimeter and an interior, the base comprising a bottom surface configured to contact skin of a patient and comprising a first opening in the per...
|
|
WO/2023/218254A1 |
The invention relates to a curable immobilisation dressing comprising a substrate element in form of a flexible sleeve made of knitted fabric with a meshed weave, and a curable element in form of a flexible sleeve made of knitted fabric ...
|
|
WO/2023/215453A1 |
A medical patch can comprise a biocompatible substrate and a dry hydrogel precursor layer on the substrate, the dry hydrogel precursor layer comprising an electrophilic-hydrogel precursor having a plurality of electrophilic functional gr...
|
|
WO/2023/209788A1 |
In the present embodiment, the production apparatus is provided with a first injection device, a second injection device, a control device, and a pouring device. The first injection device injects calcium hydroxide into a container. The ...
|
|
WO/2023/211384A1 |
There is provided a regenerative material for skin, bone and/or cartilage tissue regeneration, the material comprising, a hyaluronic acid-based synthetic copolymer having one or more repeating units represented by general formula (Vlll-a...
|
|
WO/2023/211931A1 |
Disclosed herein are tissue augmentation compositions comprising a hydrogel modified with methacrylic anhydride. The hydrogel may be composed of albumin, collagen, silk, or keratin. The composition may be used to modulate an immune respo...
|
|
WO/2023/203402A1 |
Pressure sensitive adhesive articles include a substrate with a first major surface and a second major surface, and a pressure sensitive adhesive layer disposed on at least a portion of the first major surface of the substrate. The press...
|
|
WO/2023/199057A1 |
Compositions for preventing and treating bacterial infections include artificial sweeteners such as ace-k, saccharin and cyclamate. The compositions are particularly envisaged for topical administration for treating skin infections and f...
|
|
WO/2023/198086A1 |
Disclosed is an antibacterial healing-promoting functionalized dressing, comprising a bottom lining layer, a polyurethane foam layer and an antibacterial healing-promoting functional layer which are sequentially bonded, the antibacterial...
|
|
WO/2023/198959A1 |
The invention relates to an adhesive body dressing (10) comprising a backing layer (B) and a hydrocolloid adhesive layer (H), the backing layer (B) is a film layer or a foam layer comprising a first side (B1) and a second side (B2), the ...
|
|
WO/2023/198958A1 |
The invention relates to an adhesive body dressing (10) comprising a backing layer (B) and a hydrocolloid adhesive layer (H). The hydrocolloid adhesive layer (H) is provided directly on the first side (B1) of backing layer (B). The hydro...
|
|
WO/2023/199855A1 |
The purpose of the present invention is to provide: a copolymer that can impart excellent biocompatibility to the surface of a medical device by a simple process and enables the biocompatibility to be kept for a long period of time; a me...
|
|
WO/2023/196422A1 |
A dehydrated, partially perforated, placental tissue allograft that can be used in the treatment of wounds. Specifically, the dehydrated, partially perforated placental allograft has the property of being able to be cleaned during proces...
|
|
WO/2023/196763A1 |
The subject invention provides topical therapeutic compositions and methods of their use for enhanced healing of wounds, including bums, and scars of the skin. Specifically, in one embodiment, the subject invention provides materials and...
|
|
WO/2023/196675A1 |
The present disclosure is directed to a layered band for incorporating into wearable medical device, wherein the band works to simultaneously activate, tighten, and elongate muscles. Embodiments of the present disclosure include pairs of...
|
|
WO/2023/192323A1 |
The present disclosure provides attachment systems to a parent device, namely, a latticed orthopedic support, and accessory devices for a variety of achievements.
|
|
WO/2023/191184A1 |
The present invention relates to a hyaluronate nonwoven fabric using a hyaluronate fiber and to a method for manufacturing same and, more specifically, to a highly functional hyaluronate nonwoven fabric made of a hyaluronate fiber having...
|
|
WO/2023/190492A1 |
Provided is a method for producing a water-absorbing resin composition, the method imparting high gel stability, suppressing an increase in the amount of water-absorbing resin particles that are dissolved by a sulfite compound, and suppr...
|
|
WO/2023/187345A1 |
The present invention provides a composite hydrogel comprising: (a) an anionic or cationic functional group-containing polymer; and (b) at least one active pharmaceutical ingredient (API), wherein the API is oppositely charged to the ani...
|
|
WO/2023/190401A1 |
A pulp sheet for fluff pulp according to one embodiment of the present invention contains bleached hardwood kraft pulp and bleached softwood kraft pulp. When the content is calculated for all pulp fibers at fiber length intervals of 0.02...
|
|
WO/2023/188980A1 |
The present invention addresses the problem of providing a hydrogel in which a large amount of volatile components can be stably dispersed and which has superior ability in releasing volatile components in a sustained manner. Provided ...
|
|
WO/2023/181563A1 |
Provided is an anti-adhesive material containing particles, in which the particles comprise a crosslinked product of a gelatin mixture composed of a first gelatin and a second gelatin having such a structure that a hydrocarbon group is i...
|
|
WO/2023/179884A1 |
Suggested is the use of at least one fragrance having a molecular weight between 95 to 225 g/mol as a urease inhibitor.
|
|
WO/2023/176501A1 |
A biocompatible member according to an embodiment of the present invention has multiple fibers containing a biocompatible material. The adjacent fibers are covalently bonded to each other at multiple places in the direction in which the ...
|
|
WO/2023/172751A1 |
Device and methods for treating wounds or surgical sites are provided. The devices and methods include use of antifibrinolytic agents such as tranexamic acid to reduce exudate and improve wound healing. Embodiments provide for the timed ...
|
|
WO/2023/173063A2 |
Provided are reusable face masks comprising a single piece mask body configured to cover a nose and a mouth of a human face and comprising at least one filter attachment port, wherein the at least one filter attachment port comprises a c...
|
|
WO/2023/169647A1 |
A sanitary article, such as a sanitary pad, a pantyliner, a pant diaper or an open diaper, according to the present disclosure comprises a fluid permeable topsheet and a backsheet. The sanitary article extends in a longitudinal direction...
|
|
WO/2023/168616A1 |
An absorbent article (20), such as a diaper, comprising a liquid-permeable topsheet (24), an upper acquisition-distribution system (52, 54), an absorbent core (28) comprising a layer of superabsorbent polymer particles (60) disposed in a...
|
|
WO/2023/170558A1 |
The present invention relates to a method for preparing a system for controlled release of antibiotics and bioactive factors, which is formed by microspheres in a hydrogel, wherein the method comprises synthesising W1/O/W2 microspheres t...
|
|
WO/2023/170148A1 |
The present invention relates to biodegradable, non-porous medical devices and particular to such devices comprising a sheet-like structural layer and a multi- layered water-activatable adhesive component. The invention further relates t...
|
|
WO/2023/160772A1 |
The present invention relates to a skin dressing for topical delivery of an active agent, such as nitric oxide, comprising a covering layer, an absorbent layer, a first compartment comprising a first reactant, wherein the first reactant ...
|
|
WO/2023/161828A1 |
Described herein are compositions of EDTA having activity against planktonic and biofilm cells of clinically relevant pathogens. The compositions generally include EDTA and are capable of inhibiting the growth and proliferation of microb...
|
|
WO/2023/164086A1 |
An antimicrobial prosthetic liner having an exterior fabric layer and an inner layer comprising a thermoplatic and further incorporating evenly distributed nanoparticles of certain metal oxide nanoparticles in an amount ranging from 2 %-...
|
|
WO/2023/164113A1 |
Surgical stapling devices have a surgical buttress attached to an anvil jaw member, a cartridge jaw member, or both. In use, the surgical buttress reinforces a staple line formed upon application of staples from the surgical stapling dev...
|
|
WO/2023/156851A1 |
The present invention relates to a synthesis method of a series of new biodegradable, hydrophilic materials in the form of a film and prepared from a semi-impenetrable network (semi-IPN) of poly(3-hydroxybutyrate-co-3-valerate) and cross...
|
|
WO/2023/156749A1 |
The invention relates to a polymerisable composition for use as an adhesive for biological tissue, in particular for non-mineralised biological tissue, comprising an acrylate-type polymerisable monomer, a photoinitiator and a photopolyme...
|
|
WO/2023/154736A1 |
Some tissue adhesives include a solid having bio-absorbable fibers and at least one of nano-spheres, micro-spheres, nano-tubules, or micro-tubules. A first layer of the solid has a positive Poisson's ratio and a second layer of the solid...
|
|
WO/2023/149728A1 |
The present invention relates to a biodegradable resin composition and a medical splint comprising same. The biodegradable resin composition may comprise: a compatibilizer including polylactide (PLA-g-GMA) grafted using polylactide (PLA)...
|
|
WO/2023/144301A1 |
The present invention relates to the use of neutral core human milk oligosaccharides such as in particular lacto-N-(neo)tetraoses as anti-ageing active ingredient as well as the use thereof in topical anti-ageing compositions.
|
|
WO/2023/140719A1 |
An aspect relates to a microfluidic device and use thereof. The microfluidic device of the present invention comprises one or more micro-pillars therein, and thus, when blood flow forms inside the device, shear stress is generated by the...
|
